Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: The role of inflammatory biomarkers

doi:10.5492/wjccm.v8.i5.59

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9509)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-2) series.

Item

Count

PDF

582

WORD

231

HTML

6610

Tables (1-2)

228

Sum=7651

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

857

Download

1000

Sum=1857

Sep 11, 2019 (publication date) through Aug 24, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Critical Care Medicine

ISSN

2220-3141

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Crit Care Medl. Sep 11, 2019; 8(5): 59-71
Published online Sep 11, 2019. doi: 10.5492/wjccm.v8.i5.59

Table 2 Biomarkers in acute respiratory distress syndrome[44]

Pathways	Biomarkers
Epithelial	RAGE
	SP-D
	KL-6
	CC16
	KGF
Endothelial	Ang-1/2
	vWF
	VEGF
Inflammatory	Pro-inflammatory	IL-1β
		IL-6
		TNFα
		IL-8
		IL-18
	Anti-Inflammatory	ILRA
		sTNF-RI/II
		IL-10
Coagulation and Fibrinolysis	PAI-1

RAGE: Receptor for advanced glycation end-product; SP-D: Serum surfactant protein D; KL-6: Kreb von den Lungen-6; CC16: Clara cell secretory protein; KGF: Keratinocyte growth factor; Ang 1/2: Barrier stabilizing angiopoietin 1/2; vWF: Von willebrand factor; VEGF: Vascular endothelial growth factor; IL: Interleukin; sTNF-RI/II: Soluble tissue necrosis factor receptor I/II; PAI-1: Plasminogen activator inhibitor-a.

Citation: Chalmers S, Khawaja A, Wieruszewski PM, Gajic O, Odeyemi Y. Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: The role of inflammatory biomarkers. World J Crit Care Medl 2019; 8(5): 59-71
URL: https://www.wjgnet.com/2220-3141/full/v8/i5/59.htm
DOI: https://dx.doi.org/10.5492/wjccm.v8.i5.59